I agree that PPHM stock could move up at any time. I don't agree that it will move a lot for no reason. Skepticism is the word for the market in general and doubly so for mircobios like Peregrine.
That said, I suspect the dozens of pre-clinical collaborations could spawn impressive results in one or more combination. If so, the market might like the PR. More importantly, a collaborating BP might like it enough to partner or buy Peregrine.
Of course, failing the collaboration good news route, there is the chance that a mid-2015 look-in from the Sunrise trial could move us into a much better market neighborhood.
Hoping for a Very Happy Peregrine New Year,
Paul